230 related articles for article (PubMed ID: 1902453)
1. Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry.
Shimomatsuya T; Tanigawa N; Muraoka R
Jpn J Cancer Res; 1991 Mar; 82(3):357-62. PubMed ID: 1902453
[TBL] [Abstract][Full Text] [Related]
2. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
3. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine.
Erba E; Giordano M; Danova M; Mazzini G; Ubezio P; Torri V; Mangioni C; Landoni F; Bolis P; Tenti P
Ann Oncol; 1994 Sep; 5(7):627-34. PubMed ID: 7993839
[TBL] [Abstract][Full Text] [Related]
4. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
[TBL] [Abstract][Full Text] [Related]
5. Correlation of DNA ploidy and proliferative activity in human gastric cancer.
Yonemura Y; Sugiyama K; Fujimura T; De Aretxabala X; Kamata T; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Cancer; 1988 Oct; 62(8):1497-502. PubMed ID: 3167767
[TBL] [Abstract][Full Text] [Related]
6. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry.
Sarkaria JN; Gibson DF; Jordan VC; Fowler JF; Lindstrom MJ; Mulcahy RT
Cancer Res; 1993 Sep; 53(18):4413-7. PubMed ID: 8364937
[TBL] [Abstract][Full Text] [Related]
8. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
9. Growth of human prostate carcinomas with and without hormone alpha- dehydrotestosterone in nude mice.
Baisch H; Otto U; Fack H
Eur Urol; 1998 Dec; 34(6):505-11. PubMed ID: 9831793
[TBL] [Abstract][Full Text] [Related]
10. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of the kinetics of cell proliferation of cancer of the oropharynx in vivo by the incorporation of bromodeoxyuridine and flow cytometry].
Bourhis J; Wilson GD; Janot F; Chavaudra N; Leridant AM; Wibault P; Girinsky T; Luboinski B; Eschwege F; Malaise EP
Bull Cancer; 1991 Nov; 78(11):1045-51. PubMed ID: 1369550
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
[TBL] [Abstract][Full Text] [Related]
13. Cellular kinetics in rectal cancer.
Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.
Rostagno P; Moll JL; Birtwisle-Peyrottes I; Ettore F; Lagrange JL; Gioanni J; Caldani C
Anticancer Res; 1994; 14(5A):2025-32. PubMed ID: 7531416
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
Wilson GD; McNally NJ; Dische S; Saunders MI; Des Rochers C; Lewis AA; Bennett MH
Br J Cancer; 1988 Oct; 58(4):423-31. PubMed ID: 3207597
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
17. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot?
Haustermans K; Fowler J; Geboes K; Christiaens MR; Lerut A; van der Schueren E
Radiother Oncol; 1998 Feb; 46(2):157-67. PubMed ID: 9510043
[TBL] [Abstract][Full Text] [Related]
18. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1992 Jan; 69(2):314-21. PubMed ID: 1728362
[TBL] [Abstract][Full Text] [Related]
20. Combined flow cytometry and immunohistochemistry analyses for the assessment of nasopharyngeal carcinoma cell kinetics by in vivo bromodeoxyuridine infusion.
Marchal S; Marchal C; Parache RM; Benjaafar N; Odda M; Leclerc A; Merlin JL; el Gueddarri B; Bey P
Cytometry; 1997 Oct; 29(2):165-72. PubMed ID: 9332823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
